NP

Neelam Pankaj Chaurasia

Active Director Director DIN 08626369
DIN 08626369 First appointment Dec 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value •••• Premium profile

About Neelam Pankaj Chaurasia

Data last updated:

Neelam Pankaj Chaurasia is a Director at Smear India Healthcare Private Limited (since 2019). The company operates in Trading. Smear India Healthcare Private Limited reported revenue of ₹1.21 Cr (FY 2025).

DIN 08626369
Primary Designation Director
Industry Trading
First Appointment 03 Dec 2019
Oldest Company Age 12 yrs
Largest company Smear India Healthcare Private Limited · ₹1.21 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Dec 20192013₹1.21 Cr (FY 2025)Active

Board colleagues of Neelam Pankaj Chaurasia

Directorship timeline

Open interactive timeline →
Smear India Healthcare Private Limited
Premium access

Shareholding and investment profile for Neelam Pankaj Chaurasia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelam Pankaj Chaurasia

Neelam Pankaj Chaurasia currently holds 1 directorship: Smear India Healthcare Private Limited (Director, since 03 Dec 2019, revenue ₹1.21 Cr (FY 2025)).

Neelam Pankaj Chaurasia was first appointed on 03 Dec 2019 as Director at Smear India Healthcare Private Limited.

The current boards of Neelam Pankaj Chaurasia's companies include Pankaj Mahavir Chaurasia (Smear India Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available